Drug intelligence / Profile preview

ambrosia confertiflora pollen extract

Development stage
Unknown
Lead developer
Ares Life Sciences
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Percutaneous, Intradermal, Epicutaneous
01

Overview

Ambrosia confertiflora pollen extract, derived from slimleaf ragweed, is a biological allergen extract used for both the diagnosis and treatment of ragweed-induced allergic conditions. As a diagnostic tool, it is utilized in skin prick or intradermal testing to identify IgE-mediated hypersensitivity. Therapeutically, it is administered via subcutaneous immunotherapy (SCIT), where gradual exposure to increasing doses of the allergen induces immunological tolerance. This process involves shifting the immune response from a Th2-mediated allergic profile to a Th1 and regulatory T-cell (Treg) response, leading to the production of IL-10 and IgG4 blocking antibodies, which compete with IgE for allergen binding, and a subsequent reduction in mast cell and basophil activation and mediator release.

Other names
Slimleaf ragweed pollen extractWeakleaf ragweed pollen extractSlimleaf bursage pollen extractAmbrosia confertiflora pollen
02

Targets

IgE (Immunoglobulin E)A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)IL10 (Interleukin-10)IL-4 (Interleukin 4)

Beyond the preview

Go deeper on ambrosia confertiflora pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ambrosia confertiflora pollen extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call